The Bombay High Court on Wednesday allowed healthcare company Johnson & Johnson to manufacture its baby powder at the Mulund plant in Maharashtra but prohibited its sale or distribution, reported Bar and Bench.
A division bench of Justices SV Gangapurwala and SG Dige also directed the state Food and Drug Administration to send fresh samples of the baby powder from the facility to three laboratories for re-testing.
The product samples will be sent to Central Drug Testing Laboratory, Western Zone, Food and Drug Administration laboratory at Bandra-Kurla Complex, and a private lab called Intratech Laboratory, reported Bar and Bench.
Johnson & Johnson faces about 38,000 lawsuits that claim its talcum products cause cancer due to contamination with asbestos. The product had been discontinued in the United States and Canada in 2020. On August 11, the company had announced that it will stop selling its baby talcum powder globally from 2023.
The High Court passed the order on Wednesday after hearing Johnson & Johnson’s plea challenging the state government order on September 15 cancelling the company’s license to manufacture the product, effective from December 15, reported Bar and Bench.
The order banning the product came after the Food and Drug Administration during a random inspection took samples of the talc-based baby powder for a quality check in…